Search

Your search keyword '"Duvvuri, Umamaheswar"' showing total 934 results

Search Constraints

Start Over You searched for: Author "Duvvuri, Umamaheswar" Remove constraint Author: "Duvvuri, Umamaheswar"
934 results on '"Duvvuri, Umamaheswar"'

Search Results

201. The impact of tumor hypoxia on the clinical efficacy of anti-PD-1 mAb treatment in recurrent/metastatic HNSCC patients (R/M).

202. Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

203. Distinct B cell signatures and tertiary lymphoid structures are driven by two etiol-ogies in head and neck cancer

205. Transition to a virtual multidisciplinary tumor board during the COVID ‐19 pandemic: University of Pittsburgh experience

209. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

212. Sinusitis

213. Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.

216. Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response

220. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma.

221. Contributory presentations/posters

222. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

223. Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients

225. HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma

227. Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage

230. Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer

232. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.

233. Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.

234. Robot-assisted neck dissection.

235. Quality and Readability Assessment of Websites on Human Papillomavirus and Oropharyngeal Cancer.

236. Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta‐analysis.

237. Effect of transcervical arterial ligation on the severity of postoperative hemorrhage after transoral robotic surgery

238. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2

239. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx

241. Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.

242. Reconstruction of TORS oropharyngectomy defects with the nasoseptal flap via transpalatal tunnel.

245. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

247. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort

248. The mutational landscape of recurrent versus nonrecurrent human papillomavirus–related oropharyngeal cancer

249. Abstract CT135: A pre-surgical window of opportunity study to investigate the biomarker effects of DNA damage response (DDR) agents in patients (pts) with head and neck squamous cell carcinoma (HNSCC)

250. Abstract CT058: Molecular and clinical activity of CDX-3379, an anti-ErbB3 monoclonal antibody, in head and neck squamous cell carcinoma: A preoperative "window of opportunity" study

Catalog

Books, media, physical & digital resources